Charting, Price Performance, News & Related Contracts.

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, ...

Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced that its push notification ...

Interactive Brokers Group, Inc. (NASDAQ:IBKR – Get Free Report) was the target of unusually large options trading activity on Wednesday. Stock traders bought 3,850 call options on the company. This is ...

Aurora Cannabis Inc. closed 58.72% short of its 52-week high of $9.35, which the company reached on April 30th.

CVB Financial Corp. reported net income of $50.9 million for the quarter ended December 31, 2024, compared with $51.2 million ...

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to ...

AURORA, IL / ACCESS Newswire / January 22, 2025 / Old Second Bancorp, Inc. (the "Company," "Old Second," "we," "us," and "our") (NASDAQ:OSBC), the parent company of Old Second National Bank (the "Bank ...

MacKenzie Realty Capital, Inc. ("MacKenzie" or the "Company") is pleased to announce an update on its development called Aurora at Green Valley, in Fairfield, CA. Highlights: Our Aurora project is ...

Shares of Aurora Cannabis Inc. ACB advanced 1.30% to $3.90 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.64% to ...

BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a leader in blockchain infrastructure and technology, has announced its participation in a fireside chat hosted by H.C. Wainwright & Co. This ...

Bitopertin is an investigational agent and is not approved for use as a therapy in any jurisdiction worldwide. Disc obtained global rights to bitopertin under a license agreement from Roche in May ...